SCHEMBL1007106

SCHEMBL1007106

CC1CN(C(=O)OC(C)(C)C)CCN1c1nc2c(C(=O)O)cc(Cl)cc2o1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMARCA2 P51531 1/20 0.43
SMARCA4 P51532 1/20 0.43
PBRM1 Q86U86 1/20 0.43
ABCB1 P08183 1/20 0.41
GPR119 Q8TDV5 11/20 0.40
MAPT P10636 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
USP2 O75604 1/20 0.37
HPGD P15428 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
THRB P10828 1/20 0.37
STS P08842 2/20 0.37
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1007104 1.00 SMARCA2 (0.43) SMARCA2SMARCA4PBRM1ABCB1GPR119
SCHEMBL1006680 0.91 SMARCA2 (0.42) SMARCA2SMARCA4PBRM1ABCB1GPR119
SCHEMBL1006679 0.91 SMARCA2 (0.42) SMARCA2SMARCA4PBRM1ABCB1GPR119
SCHEMBL17798227 0.88 SMARCA2 (0.41) SMARCA2SMARCA4PBRM1ABCB1GPR119
SCHEMBL17798224 0.88 SMARCA2 (0.41) SMARCA2SMARCA4PBRM1ABCB1GPR119
SCHEMBL17798281 0.88 SMARCA2 (0.41) SMARCA2SMARCA4PBRM1ABCB1GPR119
SCHEMBL1003297 0.87 KMT2A (0.36) SMARCA2SMARCA4PBRM1ABCB1GPR119
SCHEMBL17744635 0.85 SMARCA2 (0.43) SMARCA2SMARCA4PBRM1ABCB1GPR119
SCHEMBL17744701 0.85 SMARCA2 (0.43) SMARCA2SMARCA4PBRM1ABCB1GPR119
SCHEMBL1003480 0.85 ABCB1 (0.44) SMARCA2SMARCA4PBRM1ABCB1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863271-B2 2-aminobenzoxazole carboxamides as 5HT3 modulators ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-04 US disclosed
EP-2061460-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS Albany Molecular Research, Inc. (US) 2009-05-27 EP disclosed
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS AMR TECHNOLOGY, INC. (US) 2008-10-16 US disclosed
WO-2008019372-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS ALBANY MOLECULAR RESEARCH, INC. (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS HTR3E, HTR3C, HTR3A SMARCA2 1854/4885SMARCA4 1650/4885PBRM1 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.